Overview

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University
Treatments:
Imiquimod